Jaap van Dissel
Emeritus hoogleraar Inwendige Geneeskunde, in het bijzonder de infectieziekten
- Naam
- Prof.dr. J.T. van Dissel
- Telefoon
- 071 5269111
- j.t.van_dissel@lumc.nl
- ORCID iD
- null
Hoofdfunctie (vanaf 2013, 4 dagen per week): directeur van het Centrum voor Infectieziektebestrijding van het Rijksinstituut voor Volksgezondheid en Milieu, agentschap van het Ministerie van Volksgezondheid, Welzijn en Sport. Nevenfunctie (nog voor 1 dag per week sedert 2013, eerder fulltime 1999-2013): hoogleraar Interne Geneeskunde, in het bijzonder infectieziekten aan het LUMC.
Meer informatie over Jaap van Dissel
Hoofdfunctie (vanaf 2013, 4 dagen per week): directeur van het Centrum voor Infectieziektebestrijding van het Rijksinstituut voor Volksgezondheid en Milieu, agentschap van het Ministerie van Volksgezondheid, Welzijn en Sport. Nevenfunctie (nog voor 1 dag per week sedert 2013, eeder fulltime 1999-2013): hoogleraar Interne Geneeskunde, in het bijzonder infectieziekten aan het LUMC.
Infectieziekten
Voor zijn overgang naar het CIb-RIVM in 2013 was Jaap van Dissel hoofd van de afdeling Infectieziekten bij het LUMC. Daarnaast was hij hoofdopleider Interne Geneeskunde, en voorzitter van het Centrum voor Infectieziekten. Tevens was hij lid van de Gezondheidsraad, het Medisch Tuchtcollege en vice-voorzitter van het College ter Beoordeling van Geneesmiddelen en van de Scientific Advisory Group Anti-infectives bij het European Medicines Agency. Hij wisselde zijn carrière bij het LUMC – gericht op afweerstoornissen en klinische infectieziekten – af met een onderzoeksperiode bij het Duke University Medical Center in Durham en het Cold Spring Harbor Laboratory in de Verenigde Staten waar hij onderzoek deed op het gebied van bacteriele genetica.
Wetenschappelijke carrière
Promotie: “Divergent bactericidal activity of resident and activated macrophages for Salmonella typhimurium and Listeria monocytogenes” (3 december 1987).
Oratie: “Overleven in vóórtdurende onrust” (19 mei 2000).
Emeritus hoogleraar Inwendige Geneeskunde, in het bijzonder de infectieziekten
- Faculteit Geneeskunde
- Divisie 2
- Infectieziekten
- Haver, A.; Theijn, R.; Grift, I.D.; Raaijmakers, G.; Poorter, E.; Laros, J.F.J.; Dissel, J.T. van & Lodder, W.J. (2023), Regional reemergence of a SARS-CoV-2 Delta lineage amid an Omicron wave detected by wastewater sequencing, Scientific Reports 13(1).
- Niewold, P.; Dijkstra, D.J.; Cai, Y.; Goletti, D.; Palmieri, F.; Meijgaarden, K.E. van; Verreck, F.A.W.; Akkerman, O.W.; Hofland, R.W.; Delemarre, E.M.; Nierkens, S.; Verheul, M.K.; Pollard, A.J.; Dissel, J.T. van; Ottenhoff, T.H.M.; Trouw, L.A. & Joosten, S.A. (2023), Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q, Scientific Reports 13(1).
- Mac Donald-Ottevanger, M.S.; Prins, M.; Dissel, J. van; Rier, N.; Reimerink, J.; Zijlmans, W.C.W.R.; Vreden, S.G.S. & Boyd, A. (2023), Ethnic differences in hepatitis A and E virus seroprevalence in patients attending the Emergency Department, Paramaribo, Suriname, Transactions of The Royal Society of Tropical Medicine and Hygiene 117(3): 197-204.
- Ewijk, C.E. van; Miura, F.; Rijckevorsel, G. van; Vries, H.J. de; Welkers, M.R.A.; Berg, O.E. van den; Friesema, I.H.M.; Berg, P.R. van den; Dalhuisen, T.; Wallinga, J.; Brandwagt, D.; Cleef, B.A.G.L. van; Vennema, H.; Voordouw, B.; Koopmans, M.; Eijk, A.A. van der; Swaan, C.M.; Wierik, M.J.M. te; Leenstra, T.; Coul, E.O. de; Franz, E. & Dutch Mpox Response Team (2023), Mpox outbreak in the Netherlands, 2022, Eurosurveillance 28(12).
- Esmeijer, K.; Schoe, A.; Ruhaak, L.R.; Hoogeveen, E.K.; Soonawala, D.; Romijn, F.P.H.T.M.; Shirzada, M.R.; Dissel, J.T. van; Cobbaert, C.M. & Fijter, J.W. de (2021), The predictive value of TIMP-2 and IGFBP7 for kidney failure and 30-day mortality after elective cardiac surgery, Scientific Reports 11(1).
- Smits, B.M.; Budde, I.K.; Vries, E. de; Berge, I.J.M. ten; Bredius, R.G.M.; Deuren, M. van; Dissel, J.T. van; Ellerbroek, P.M.; Flier, M. van der; Hagen, P.M. van; Nieuwhof, C.; Rutgers, B.; Sanders, L.E.A.M.; Simon, A.; Kuijpers, T.W. & Montfrans, J.M. van (2020), Immunoglobulin replacement therapy versus antibiotic prophylaxis as treatment for incomplete primary antibody deficiency, Journal of Clinical Immunology 41.
- Groeneveld, G.H.; Marbus, S.D.; Ismail, N.; Vries, J.J. de; Schneeberger, P.; Oosterheert, J.J.; Dissel, J.T. van & Boer, M.G.J. de (2020), Effectiveness of oseltamivir in reduction of complications and 30-day mortality in severe seasonal influenza infection, International Journal of Antimicrobial Agents 56(5).
- Lestrade, P.P.A.; Buil, J.B.; Beek, M.T. van der; Kuijper, E.J.; Dijk, K. van; Kampinga, G.A.; Rijnders, B.J.A.; Vonk, A.G.; Greeff, S.C. de; Schoffelen, A.F.; Dissel, J. van; Meis, J.F.; Melchers, W.J.G. & Verweij, P.E. (2020), Paradoxal trends in Azole-Resistant Aspergillus fumigatus in a National Multicenter Surveillance Program, the Netherlands, 2013-2018, Emerging Infectious Diseases 26(7): 1447-1455.
- Overbosch, F.; Boer, M. de; Veldkamp, K.E.; Ellerbroek, P.; Bleeker-Rovers, C.P.; Goorhuis, B.; Vugt, M. van; Eijk, A. van der; Leenstra, T.; Khargi, M.; Ros, J.; Brandwagt, D.; Haverkate, M.; Swaan, C.; Reusken, C.; Timen, A.; Koopmans, M.; Dissel, J. van & Lassa Fever Response Team Netherla (2020), Public health response to two imported, epidemiologically related cases of Lassa fever in the Netherlands (ex Sierra Leone), November 2019, Eurosurveillance 25(15): 6-10.
- Reusken, C.B.; Buiting, A.; Bleeker-Rovers, C.; Diederen, B.; Hooiveld, M.; Friesema, I.; Koopmans, M.; Kortbeek, T.; Lutgens, S.P.M.; Meijer, A.; Murk, J.L.; Overdevest, I.; Trienekens, T.; Timen, A.; Bijllaardt, W. van den; Dissel, J. van; Gageldonk-Lafeber, A. van; Vegt, D. van der; Wever, P.C.; Hoek, W. van der & Kluytmans, J. (2020), Rapid assessment of regional SARS-CoV-2 community transmission through a convenience sample of healthcare workers, the Netherlands, March 2020, Eurosurveillance 25(12): 6-14.
- Schoe, A.; Bakhshi-Raiez, F.; Keizer, N. de; Dissel, J.T. van & Jonge, E. de (2020), Mortality prediction by SOFA score in ICU-patients after cardiac surgery, BMC Anesthesiology 20(1).
- Marbus, S.D.; Schweitzer, V.A.; Groeneveld, G.H.; Oosterheert, J.J.; Schneeberger, P.M.; Hoek, W. van der; Dissel, J.T. van; Gageldonk-Lafeber, A.B. van & Mangen, M.J. (2020), Incidence and costs of hospitalized adult influenza patients in the Netherlands, European Journal of Health Economics 21(5): 775-785.
- Groeneveld, G.H.; Reyden, T.J. van der; Joosten, S.A.; Bootsma, H.J.; Cobbaert, C.M.; Vries, J.J.C. de; Kuijper, E.J. & Dissel, J.T. van (2019), Non-lytic antibiotic treatment in community-acquired pneumococcal pneumonia does not attenuate inflammation: the PRISTINE trial, Journal of Antimicrobial Chemotherapy 74(8): 2385-2393.
- Bauer, M.P.; Timen, A.; Vossen, A.C.T.M. & Dissel, J.T. van (2019), Marburg haemorrhagic fever in returning travellers: an overview aimed at clinicians, Clinical Microbiology and Infection 21: E28-E31.
- Dissel, J.T. van; Pieters, T.; Geluk, A.; Maat, G.; Menke, H.E.; Tio-Coma, M.; Altena, E.; Laros, J.F.J. & Adhin, M.R. (2019), Archival, paleopathological and aDNA-based techniques in leprosy research and the case of Father Petrus Donders at the Leprosarium 'Batavia', Suriname, International Journal of Paleopathology 27: 1-8.
- Tio-Coma, M.; Sprong, H.; Kik, M.; Dissel, J.T. van; Han, X.Y.; Pieters, T. & Geluk, A. (2019), Lack of evidence for the presence of leprosy bacilli in red squirrels from North-West Europe, Transboundary and Emerging Diseases.
- Kooi, T.I.I. van der; Boshuizen, H.; Wille, J.C.; Greeff, S.C. de; Dissel, J.T. van; Schoffelen, A.F. & Gaalen, R.D. van (2019), Using flexible methods to determine risk factors for ventilator-associated pneumonia in the Netherlands, PLoS ONE 14(6).
- Groeneveld, G.H.; Peppel, R.J. van de; Waal, M.W.M. de; Verheij, T.J.M. & Dissel, J.T. van (2019), Clinical factors, C-reactive protein point of care test and chest X-ray in patients with pneumonia: A survey in primary care, European Journal of General Practice 25(4): 229-235.
- Dijkmans, A.C.; Kweekel, D.M.; Dissel, J.T. van; Esdonk, M.J. van; Kamerling, I.M.C. & Burggraaf, J. (2019), The Oral Pheneticillin Absorption Test: An Accurate Method to Identify Patients with Inadequate Oral Pheneticillin Absorption, Antibiotics 8(3).
- Stalenhoef, J.E.; Nieuwkoop, C. van; Wilson, D.C.; Starre, W.E. van der; Reijden, T.J.K. van der; Delfos, N.M.; Leyten, E.M.S.; Koster, T.; Ablij, H.C.; Wout, J.W. van 't & Dissel, J.T. van (2019), Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection, BMC Infectious Diseases 19.
- Groeneveld, G.H.; van't Wout, J.W.; Aarts, N.J.; Rooden, C.J. van; Verheij, T.J.M.; Cobbaert, C.M.; Kuijper, E.J.; Vries, J.J.C. de & Dissel, J.T. van (2019), Prediction model for pneumonia in primary care patients with an acute respiratory tract infection: role of symptoms, signs, and biomarkers, BMC Infectious Diseases 19(1).
- Paassen, J.; Dissel, J.T. van; Hiemstra, P.S.; Zwaginga, J.J.; Cobbaert, C.M.; Juffermans, N.P.; Wilde, R.B. de; Stijnen, T.; Jonge, E. de; Klautz, R.J. & Arbous, M.S. (2019), Perioperative proADM-change is associated with the development of acute respiratory distress syndrome in critically ill cardiac surgery patients: a prospective cohort study, Biomarkers in Medicine 13(13): 1081-1091.
- Stalenhoef, J.E.; Nieuwkoop, C. van; Menken, P.H.; Bernards, S.T.; Elzevier, H.W. & Dissel, J.T. van (2019), Intravesical Gentamicin Treatment for Recurrent Urinary Tract Infections Caused by Multidrug Resistant Bacteria, Journal of Urology 201(3): 549-555.
- Groeneveld, G.H.; Veldkamp, K.E. & Dissel, J.T. van (2019), Repetitive urinary tract infections and two prostatic masses: Prostatic soft tissue infection with Actinomyces neuii, International Journal of Infectious Diseases 86: 55-56.
- Dijkmans, A.C.; Kweekel, D.M.; Balmforth, C.; Esdonk, M.J. van; Dissel, J.T. van; Burggraaf, J. & Kamerling, I.M.C. (2019), The simplified oral flucloxacillin absorption test: an accurate method to identify patients with inadequate oral flucloxacillin absorption, Netherlands Journal of Medicine 77(7): 255-260.
- Groeneveld, G.H.; Spaan, W.J.; Hoek, W. van der & Dissel, J.T. van (2018), Het intensieve griepseizoen van 2018, Nederlands Tijdschrift voor Geneeskunde 162(D3323).
- Stalenhoef, J.E.; Nieuwkoop, C. van; Wilson, D.C.; Starre, W.E. van der; Delfos, N.M.; Leyten, E.M.S.; Koster, T.; Ablij, H.C.; van't Wout, J.W. & Dissel, J.T. van (2018), Biomarker guided triage can reduce hospitalization rate in community acquired febrile urinary tract infection, Journal of Infection 77(1): 18-24.
- Groeneveld, G.H.; Paassen, J. van; Dissel, J.T. van & Arbous, M.S. (2018), Influenza Season and ARDS after Cardiac Surgery, New England Journal of Medicine 378(8): 772-773.
- Vosse, E. van de & Dissel, J.T. van (2017), IFN-gamma R1 defects: Mutation update and description of the IFNGR1 variation database, Human Mutation 38(10): 1286-1296.
- Nieuwkoop, C. van; Starre, W.E. van der; Stalenhoef, J.E.; Aartrijk, A.M. van; Reijden, T.J.K. van der; Vollaard, A.M.; Delfos, N.M.; Wout, J.W. van 't; Blom, J.W.; Spelt, I.C.; Leyten, E.M.S.; Koster, T.; Ablij, H.C.; Beek, M.T. van der; Knol, M.J. & Dissel, J.T. van (2017), Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women, BMC Medicine 15.
- Stalenhoef, J.E.; Starre, W.E. van der; Vollaard, A.M.; Steyerberg, E.W.; Delfos, N.M.; Leyten, E.M.S.; Koster, T.; Ablij, H.C.; van't Wout, J.W.; Dissel, J.T. van & Nieuwkoop, C. van (2017), Hospitalization for community-acquired febrile urinary tract infection: validation and impact assessment of a clinical prediction rule, BMC Infectious Diseases 17.
- Groeneveld, G.H.; Dalhuijsen, A.; Kara-Zaitri, C.; Hamilton, B.; Waal, M.W. de; Dissel, J.T. van & Steenbergen, J.E. van (2017), ICARES: a real-time automated detection tool for clusters of infectious diseases in the Netherlands, BMC Infectious Diseases 17.
- Jolink, H.; Boer, R. de; Hombrink, P.; Jonkers, R.E.; Dissel, J.T. van; Falkenburg, J.H.F. & Heemskerk, M.H.M. (2017), Pulmonary immune responses against Aspergillus fumigatus are characterized by high frequencies of IL-17 producing T-cells, Journal of Infection 74(1): 81-88.
- Vosse, E. van de; Ostaijen-ten Dam, M.M. van; Vermaire, R.; Verhard, E.M.; Waaijer, J.L.; Bakker, J.A.; Bernards, S.T.; Eibel, H.; Tol, M.J. van; Dissel, J.T. van & Haverkamp, M.H. (2017), Recurrent respiratory tract infections (RRTI) in the elderly: A late onset mild immunodeficiency?, Clinical Immunology 180: 111-119.
- Vlasveld, I.N.; Scheper, H.; Stalenhoef, J.; Baas, J.M. & Dissel, J. van (2017), A fatal case of metastatic squamous cell carcinoma in a patient with myositis ossificans traumatica, Netherlands Journal of Medicine 75(6): 250-252.
- Vosse, E. van de; Wengen, A. van; Meide, W.F. van der; Visser, L.G. & Dissel, J.T. van (2017), A 38-year-old woman with necrotising cervical lymphadenitis due to Histoplasma capsulatum, Infection 45(6): 917-920.
- Schoe, A.; Jonge, E. de; Klautz, R.J.M.; Dissel, J.T. van & Vosse, E. van de (2016), Single-Nucleotide Polymorphisms in the CALCA Gene Are Associated with Variation of Procalcitonin Concentration in Patients Undergoing Cardiac Surgery.
- Breij, A. de; Karnaoukh, T.G.; Schrumpf, J.; Hiemstra, P.S.; Nibbering, P.H.; Dissel, J.T. van & Visser, P.C. de (2016), The licorice pentacyclic triterpenoid component 18 beta-glycyrrhetinic acid enhances the activity of antibiotics against strains of methicillin-resistant Staphylococcus aureus, European Journal of Clinical Microbiology and Infectious Diseases 35(4): 555-562.
- Groeneveld, G.; Dalhuijsen, A.; Kara-Zaitri, C.; Hamilton, B.; Waal, M.W. de; Marbus, S.; Dissel, J.T. van & Steenbergen, J.E. van (2016), ICARES: Two years experience with a promising early warning tool for infectious disease clusters, International Journal of Infectious Diseases 53: 120-120.
- Starre, W.E. van der; Nieuwkoop, C. van; Thomson, U.; Zijderveld-Voshart, M.S.M.; Koopman, J.P.R.; Reijden, T.J.K. van der; Dissel, J.T. van & Vosse, E. van de (2015), Urinary Proteins, Vitamin D and Genetic Polymorphisms as Risk Factors for Febrile Urinary Tract Infection and Relation with Bacteremia: A Case Control Study, PLoS ONE 10(3).
- Jolink, H.; Boer, R. de; Willems, L.N.A.; Dissel, J.T. van; Falkenburg, J.H.F. & Heemskerk, M.H.M. (2015), T helper 2 response in allergic bronchopulmonary aspergillosis is not driven by specific Aspergillus antigens, Allergy 70(10): 1336-1339.
- Schreiber, F.; Kay, S.; Frankel, G.; Clare, S.; Goulding, D.; Vosse, E. van de; Dissel, J.T. van; Strugnell, R.; Thwaites, G.; Kingsley, R.A.; Dougan, G. & Baker, S. (2015), The Hd, Hj, and Hz66 flagella variants of Salmonella enterica serovar Typhi modify host responses and cellular interactions, PLoS ONE 5.
- (2015), BCG-vaccination induces divergent pro-inflammatory or regulatory T-cell responses in adults., Clinical and Vaccine Immunology.
- Pacchiarotta, T.; Derks, R.J.; Nevedomskaya, E.; Starre, W. van der; Dissel, J. van; Deelder, A. & Mayboroda, O.A. (2015), Exploratory analysis of urinary tract infection using a GC-APCI-MS platform, Analyst 140(8): 2834-2841.
- Boer, M.C.; Prins, C.; Meijgaarden, K.E. van; Dissel, J.T. van; Ottenhoff, T.H.M. & Joosten, S.A. (2015), Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults, Clinical and Vaccine Immunology 22(7): 778-788.
- Jong, H.K. de; Achouiti, A.; Koh, G.C.K.W.; Parry, C.M.; Baker, S.; Abul Faiz, M.; Dissel, J.T. van; Vollaard, A.M.; Leeuwen, E.M.M. van; Roelofs, J.J.T.H.; Vos, A.F. de; Roth, J.; Poll, T. van der; Vogl, T. & Wiersinga, W.J. (2015), Expression and Function of S100A8/A9 (Calprotectin) in Human Typhoid Fever and the Murine Salmonella Model, PLoS Neglected Tropical Diseases 9(4).
- Jonkman-Berk, B.M.; Berg, J.M. van den; Berge, I.J.M. ten; Bredius, R.G.M.; Driessen, G.J.; Dalm, V.A.S.H.; Dissel, J.T. van; Deuren, M. van; Ellerbroek, P.M.; Flier, M. van der; Hagen, P.M. van; Montfrans, J.M. van; Rutgers, A.; Scholvinck, E.H.; Vries, E. de; Beem, R.T. van & Kuijpers, T.W. (2015), Primary immunodeficiencies in the Netherlands: National patient data demonstrate the increased risk of malignancy, Clinical Immunology 156(2): 154-162.
- Schoe, A.; Schippers, E.F.; Struck, J.; Ebmeyer, S.; Klautz, R.J.M.; Jonge, E. de & Dissel, J.T. van (2015), Postoperative Pro-Adrenomedullin Levels Predict Mortality in Thoracic Surgery Patients: Comparison With Acute Physiology and Chronic Health Evaluation IV Score, Critical Care Medicine 43(2): 373-381.
- Stalenhoef, J.E.; Dissel, J.T. van & Nieuwkoop, C. van (2015), Febrile urinary tract infection in the emergency room, Current Opinion in Infectious Diseases 28(1): 106-111.
- Jolink, H.; Hagedoorn, R.S.; Lagendijk, E.L.; Drijfhout, J.W.; Dissel, J.T. van; Falkenburg, J.H.F. & Heemskerk, M.H.M. (2014), Induction of A. fumigatus-specific CD4-positive T cells in patients recovering from invasive aspergillosis.
- Lindstedt, E.W.; Bennebroek, C.A.; Werf, D.J. van der; Veckeneer, M.; Ossewaarde-van Norel, A.; Nielsen, C.C.M.; Wubbels, R.J.; Dissel, J.T. van & Meurs, J.C. van (2014), A prospective multicenter randomized placebo-controlled trial of dexamethasone as an adjuvant in the treatment of postoperative bacterial endophthalmitis: interim safety analysis of the study drug and analysis of overall treatment results, Graefe's Archive for Clinical and Experimental Ophthalmology 252(10): 1631-1637.
- Haisma, E.M.; Breij, A. de; Chan, H.; Dissel, J.T. van; Drijfhout, J.W.; Hiemstra, P.S.; Ghalbzouri, A. el & Nibbering, P.H. (2014), LL-37-Derived Peptides Eradicate Multidrug-Resistant Staphylococcus aureus from Thermally Wounded Human Skin Equivalents, Antimicrobial Agents and Chemotherapy 58(8): 4411-4419.
- Bauer, M.P.; Farid, A.; Bakker, M.; Hoek, R.A.S.; Kuijper, E.J. & Dissel, J.T. van (2014), Patients with cystic fibrosis have a high carriage rate of non-toxigenic Clostridium difficile, Clinical Microbiology and Infection 20(7): O446-O449.
- Jong, H.K. de; Koh, G.C.K.W.; Lieshout, M.H.P. van; Roelofs, J.J.T.H.; Dissel, J.T. van; Poll, T. van der & Wiersinga, W.J. (2014), Limited role for ASC and NLRP3 during in vivo Salmonella Typhimurium infection, BMC Immunology 15.
- Starre, W.E. van der; Zunder, S.M.; Vollaard, A.M.; Nieuwkoop, C. van; Stalenhoef, J.E.; Delfos, N.M.; van't Wout, J.W.; Spelt, I.C.; Blom, J.W.; Leyten, E.M.S.; Koster, T.; Ablij, H.C. & Dissel, J.T. van (2014), Prognostic value of pro-adrenomedullin, procalcitonin and C-reactive protein in predicting outcome of febrile urinary tract infection, Clinical Microbiology and Infection 20(10): 1048-1054.
- Aboutaleb, N.; Kuijper, E.J. & Dissel, J.T. van (2014), Emerging infectious colitis, Current Opinion in Gastroenterology 30(1): 106-115.
- Woei-A-Jin, F.J.S.H.; Starre, W.E. van der; Tesselaar, M.E.T.; Rodriguez, P.G.; Nieuwkoop, C. van; Bertina, R.M.; Dissel, J.T. van & Osanto, S. (2014), Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infections, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 133(5): 799-803.
- Plas, M.J.A. van der; Andersen, A.S.; Nazir, S.; Tilburg, N.H. van; Oestergaard, P.R.; Krogfelt, K.A.; Dissel, J.T. van; Hensbergen, P.J.; Bertina, R.M. & Nibbering, P.H. (2014), A Novel Serine Protease Secreted by Medicinal Maggots Enhances Plasminogen Activator-Induced Fibrinolysis, PLoS ONE 9(3).
- Knoester, M.; Boer, M.G.J. de; Maarleveld, J.J.; Claas, E.C.J.; Bernards, A.T.; Jonge, E.; Dissel, J.T. van & Veldkamp, K.E. (2014), An integrated approach to control a prolonged outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit, Clinical Microbiology and Infection 20(4): O207-O215.
- Haverkamp, M.H.; Vosse, E. van de & Dissel, J.T. van (2014), Nontuberculous mycobacterial infections in children with inborn errors of the immune system, Journal of Infection 68: S134-S150.
- Filiz, S.; Uygun, D.F.K.; Verhard, E.M.; Dissel, J.T. van; Uygun, V.; Bassorgun, C.; Bingol, A.; Yegin, O. & Vosse, E. van de (2014), Cutaneous Leukocytoclastic Vasculitis due to Salmonella enteritidis in a Child with Interleukin-12 Receptor Beta-1 Deficiency, Pediatric Dermatology 31(2): 236-240.
- Schoe, A.; Schippers, E.F.; Ebmeyer, S.; Struck, J.; Klautz, R.J.M.; Jonge, E. de & Dissel, J.T. van (2014), Predicting Mortality and Morbidity Aft er Elective Cardiac Surgery Using Vasoactive and Inflammatory Biomarkers With and Without the EuroSCORE Model, Chest 146(5): 1310-1318.
- Bauer, M.P.; Nibbering, P.H.; Poxton, I.R.; Kuijper, E.J. & Dissel, J.T. van (2014), Humoral immune response as predictor of recurrence in Clostridium difficile infection, Clinical Microbiology and Infection 20(12): 1323-1328.
- Dissel, J.T. van; Joosten, S.A.; Hoff, S.T.; Soonawala, D.; Prins, C.; Hokey, D.A.; O'Dee, D.M.; Graves, A.; Thierry-Carstensen, B.; Andreasen, L.V.; Ruhwald, M.; Visser, A.W. de; Agger, E.M.; Ottenhoff, T.H.M.; Kromann, I. & Andersen, P. (2014), A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human, Vaccine 32(52): 7098-7107.
- Knoester, M.; Boer, M.G.J. de; Maarleveld, J.J.; Claas, E.C.J.; Bernards, A.T.; Jonge, E.; Dissel, J.T. van & Veldkamp, K.E. (2014), An integrated approach to control a prolonged outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit, Clinical Microbiology and Infection 20(4): O207-O215.
- Paus, R.A. de; Wengen, A. van; Schmidt, I.; Visser, M.; Verdegaal, E.M.E.; Dissel, J.T. van & Vosse, E. van de (2013), Inhibition of the type I immune responses of human monocytes by IFN-alpha and IFN-beta, Cytokine 61(2): 645-655.
- Haisma, E.M.; Rietveld, M.H.; Breij, A. de; Dissel, J.T. van; Ghalbzouri, A. el & Nibbering, P.H. (2013), Inflammatory and Antimicrobial Responses to Methicillin-Resistant Staphylococcus aureus in an In Vitro Wound Infection Model, PLoS ONE 8(12).
- Starre, W.E. van der; Borgdorff, H.; Vollaard, A.M.; Delfos, N.M.; Wout, J.W. van 't; Spelt, I.C.; Blom, J.W.; Leyten, E.M.S.; Koster, T.; Ablij, H.C.; Dissel, J.T. van & Nieuwkoop, C. van (2013), Diabetes and the Course of Febrile Urinary Tract Infection, Diabetes Care 36(12): E193-E194.
- Paus, R.A. de; Crevel, R. van; Beek, R. van; Sahiratmadja, E.; Alisjahbana, B.; Marzuki, S.; Rimmelzwaan, G.F.; Dissel, J.T. van; Ottenhoff, T.H.M. & Vosse, E. van de (2013), The influence of influenza virus infections on the development of tuberculosis.
- Jolink, H.; Meijssen, I.C.; Hagedoorn, R.S.; Arentshorst, M.; Drijfhout, J.W.; Mulder, A.; Claas, F.H.J.; Dissel, J.T. van; Falkenburg, J.H.F. & Heemskerk, M.H.M. (2013), Characterization of the T-Cell-Mediated Immune Response Against the Aspergillus fumigatus Proteins Crf1 and Catalase 1 in Healthy Individuals.
- Landman, G.W.D.; Arend, S.M. & Dissel, J.T. van (2013), Ruxolitinib can mask symptoms and signs of necrotizing fasciitis, Journal of Infection 66(3): 296-297.
- Vosse, E. van de; Dissel, J.T. van; Palamaro, L.; Giardino, G.; Santamaria, F.; Romano, R.; Fusco, A.; Montella, S.; Salerno, M.; Ursini, M.V. & Pignata, C. (2013), The R156H variation in IL-12R beta 1 is not a mutation, Italian Journal of Pediatrics 39.
- Paus, R.A. de; Geilenkirchen, M.A.; Riet, S. van; Dissel, J.T. van & Vosse, E. van de (2013), Differential expression and function of human IL-12R beta 2 polymorphic variants, Molecular Immunology 56(4): 380-389.
- Vosse, E. van de; Haverkamp, M.H.; Ramirez-Alejo, N.; Martinez-Gallo, M.; Blancas-Galicia, L.; Metin, A.; Garty, B.; Sun-Tan, C.; Broides, A.; Paus, R.A. de; Keskin, O.; Cagdas, D.; Tezcan, I.; Lopez-Ruzafa, E.; Arostegui, J.I.; Levy, J.; Espinosa-Rosales, F.J.; Sanal, O.; Santos-Argumedo, L.; Casanova, J.L.; Boisson-Dupuis, S.; Dissel, J.T. van & Bustamante, J. (2013), IL-12R beta 1 Deficiency: Mutation Update and Description of the IL12RB1 Variation Database, Human Mutation 34(10): 1329-1339.
- Paassen, J. van; Bauer, M.P.; Arbous, M.S.; Visser, L.G.; Schmidt-Chanasit, J.; Schilling, S.; Olschlager, S.; Rieger, T.; Emmerich, P.; Schmetz, C.; Berkmortel, F. van de; Hoek, B. van; Burgel, N.D. van; Osterhaus, A.D.; Vossen, A.C.T.M.; Gunther, S. & Dissel, J.T. van (2012), Acute liver failure, multiorgan failure, cerebral oedema, and activation of proangiogenic and antiangiogenic factors in a case of Marburg haemorrhagic fever.
- Does, A.M. van der; Joosten, S.A.; Vroomans, E.; Bogaards, S.J.P.; Meijgaarden, K.E. van; Ottenhoff, T.H.M.; Dissel, J.T. van & Nibbering, P.H. (2012), The Antimicrobial Peptide hLF1-11 Drives Monocyte-Dendritic Cell Differentiation toward Dendritic Cells That Promote Antifungal Responses and Enhance Th17 Polarization, Journal of Innate Immunity 4(3): 284-292.
- Timen, A.; Isken, L.D.; Willemse, P.; Berkmortel, F. van den; Koopmans, M.P.G.; Oudheusden, D.E.C. van; Bleeker-Rovers, C.P.; Brouwer, A.E.; Grol, R.P.T.M.; Hulscher, M.L.E.J.L. & Dissel, J.T. van (2012), Retrospective Evaluation of Control Measures for Contacts of Patient with Marburg Hemorrhagic Fever, Emerging Infectious Disease 18(7): 1107-1114.
- Kilic, S.S.; Wengen, A. van; Paus, R.A. de; Celebi, S.; Meziane, B.; Hafizoglu, D.; Dissel, J.T. van & Vosse, E. van de (2012), Severe disseminated mycobacterial infection in a boy with a novel mutation leading to IFN-gamma R2 deficiency, Journal of Infection 65(6): 568-572.
- Does, A.M. van der; Hensbergen, P.J.; Bogaards, S.J.; Cansoy, M.; Deelder, A.M.; Leeuwen, H.C. van; Drijfhout, J.W.; Dissel, J.T. van & Nibbering, P.H. (2012), The Human Lactoferrin-Derived Peptide hLF1-11 Exerts Immunomodulatory Effects by Specific Inhibition of Myeloperoxidase Activity, Journal of Immunology 188(10): 5012-5019.
- Haverkamp, M.H.; Wengen, A. van; Visser, A.W. de; Kralingen, K.W. van; Dissel, J.T. van & Vosse, E. van de (2012), Pulmonary Mycobacterium abscessus: A canary in the cystic fibrosis coalmine, Journal of Infection 64(6): 609-612.
- Jong, H.K. de; Koh, G.C.; Dissel, J.T. van; Roelofs, J.J.; Poll, T. van der & Wiersinga, J. (2012), LIMITED ROLE FOR INFLAMMASOME RECEPTORS ASC AND NOD-LIKE RECEPTOR (NLRP)-3 DURING MURINE SALMONELLA TYPHIMURIUM INFECTION, Shock 37: 107-107.
- Jong, H.K. de; Achouiti, A.; Vollaard, A.M.; Koh, G.C.; Roelofs, J.J.; Dissel, J.T. van; Roth, J.; Vogl, T.; Poll, T. van der & Wiersinga, J. (2012), EXPRESSION AND FUNCTION OF MYELOID-RELATED PROTEIN (MRP)-8/14 IN TYPHOID FEVER, Shock 37: 54-55.
- Dijkmans, A.C.; Hartigh, J. den; Dissel, J.T. van & Burggraaf, J. (2012), A Simplified Oral Flucloxacillin Absorption Test for Patients Requiring Long-Term Treatment, Therapeutic Drug Monitoring 34(3): 356-358.
- Heying, R.; Wolf, C.; Beekhuizen, H.; Moelleken, M.L.; Jockenhoevel, S.; Hoylaerts, M.F.; Schmidt, K.G. & Schroten, H. (2012), Fibrin- and Collagen-Based Matrices Attenuate Inflammatory and Procoagulant Responses in Human Endothelial Cell Cultures Exposed to Staphylococcus aureus, Tissue Engineering: Parts A, B, and C 18(1-2): 147-156.
- Plantinga, T.S.; Johnson, M.D.; Scott, W.K.; Vosse, E. van de; Edwards, D.R.V.; Smith, P.B.; Alexander, B.D.; Yang, J.C.; Kremer, D.; Laird, G.M.; Oosting, M.; Joosten, L.A.B.; Meer, J.W.M. van der; Dissel, J.T. van; Walsh, T.J.; Perfect, J.R.; Kullberg, B.J. & Netea, M.G. (2012), Toll-like Receptor 1 Polymorphisms Increase Susceptibility to Candidemia.
- Jolink, H.; Hagedoorn, R.S.; Dissel, J.T. van; Falkenburg, J.H.F. & Heemskerk, M.H.M. (2012), T cells specific for the Aspergillus proteins Crf1 and catalase1 develop in patients recovering from invasive aspergillosis, Immunology 137: 734-734.
- Vosse, E. van de; Kilic, S.S.; Paus, R.A. de; Wengen, A. van; Celebi, S.; Meziane, B.; Hafizoglu, D. & Dissel, J.T. van (2012), SEVERE DISSEMINATED MYCOBACTERIAL INFECTION IN A BOY WITH A NOVEL MUTATION LEADING TO IFN-Gamma R2 DEFICIENCY, Journal of Clinical Immunology 32: 85-85.
- Paus, R.A. de; Wengen, A. van; Schmidt, I.; Visser, M.; Verdegaal, E.M.E.; Dissel, J.T. van & Vosse, E. van de (2012), IFN-a inhibits the type I immune response of human monocytes, Immunology 137: 270-270.
- Nevedomskaya, E.; Pacchiarotta, T.; Artemov, A.; Meissner, A.; Nieuwkoop, C. van; Dissel, J.T. van; Mayboroda, O.A. & Deelder, A.M. (2012), H-1 NMR-based metabolic profiling of urinary tract infection: combining multiple statistical models and clinical data, Metabolomics 8(6): 1227-1235.
- Camps, S.M.T.; Linden, J.W.M. van der; Li, Y.; Kuijper, E.J.; Dissel, J.T. van; Verweij, P.E. & Melchers, W.J.G. (2012), Rapid Induction of Multiple Resistance Mechanisms in Aspergillus fumigatus during Azole Therapy: a Case Study and Review of the Literature, Antimicrobial Agents and Chemotherapy 56(1): 10-16.
- Johnson, M.D.; Plantinga, T.S.; Vosse, E. van de; Edwards, D.R.V.; Smith, P.B.; Alexander, B.D.; Yang, J.C.; Kremer, D.; Laird, G.M.; Oosting, M.; Joosten, L.A.B.; Meer, J.W.M. van der; Dissel, J.T. van; Walsh, T.J.; Perfect, J.R.; Kullberg, B.J.; Scott, W.K. & Netea, M.G. (2012), Cytokine Gene Polymorphisms and the Outcome of Invasive Candidiasis: A Prospective Cohort Study.
- Kuijper, E.J.; Soonawala, D.; Vermont, C. & Dissel, J.T. van (2011), Household transmission of haemolytic uraemic syndrome associated with Escherichia coli O104:H4 in the Netherlands, May 2011, Eurosurveillance 16(25): 7-9.
- Haverkamp, M.H. & Dissel, J.T. van (2011), Reply to: Nontuberculous mycobacterial cervicofacial lymphadenitis in children from the multicenter, randomized, controlled trial in the Netherlands: Relevance of polymorphisms in candidate host immunity genes, International Journal of Pediatric Otorhinolaryngology 75(5): 723-724.
- Fraaij, P.L.A.; Vries, E. van der; Beersma, M.F.C.; Riezebos-Brilman, A.; Niesters, H.G.M.; Eijk, A.A. van der; Jong, M.D. de; Miranda, D.R.; Horrevorts, A.M.; Ridwan, B.U.; Wolfhagen, M.J.H.M.; Houmes, R.J.; Dissel, J.T. van; Fouchier, R.A.M.; Kroes, A.C.M.; Koopmans, M.P.; Osterhaus, A.D.M.E. & Boucher, C.A.B. (2011), Evaluation of the Antiviral Response to Zanamivir Administered Intravenously for Treatment of Critically Ill Patients With Pandemic Influenza A (H1N1) Infection, Journal of Infectious Diseases 204(5): 777-782.
- Nieuwkoop, C. van; Bergkamp, C.H.M.; Elzevier, H.W.; Pelger, R.C.M. & Dissel, J.T. van (2011), Pelvic floor dysfunction does not affect frequency or outcome of urinary tract infection in adults, European Journal of Internal Medicine 22(4): E28E30.
- van der Starre WE, van Dissel JT & van Nieuwkoop C (2011), Treatment Duration of Febrile Urinary Tract Infections., Current Infectious Disease Reports.
- Starre, W.E. van der; Nieuwkoop, C. van; Paltansing, S.; van't Wout, J.W.; Groeneveld, G.H.; Becker, M.J.; Koster, T.; Wattel-Louis, G.H.; Delfos, N.M.; Ablij, H.C.; Leyten, E.M.S.; Blom, J.W. & Dissel, J.T. van (2011), Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection, Journal of Antimicrobial Chemotherapy 66(3): 650-656.
- Chai, L.Y.A.; Boer, M.G.J. de; Velden, W.J.F.M. van der; Plantinga, T.S.; Spriel, A.B. van; Jacobs, C.; Halkes, C.J.M.; Vonk, A.G.; Blijlevens, N.M.; Dissel, J.T. van; Donnelly, P.J.; Kullberg, B.J.; Maertens, J. & Netea, M.G. (2011), The Y238X Stop Codon Polymorphism in the Human beta-Glucan Receptor Dectin-1 and Susceptibility to Invasive Aspergillosis, Journal of Infectious Diseases 203(5): 736-743.
- Vosse, E. van de; Verhard, E.M.; Tool, A.J.T.; Visser, A.W. de; Kuijpers, T.W.; Hiemstra, P.S. & Dissel, J.T. van (2011), Severe congenital neutropenia in a multigenerational family with a novel neutrophil elastase (ELANE) mutation, Annals of Hematology 90(2): 151-158.
- Boer, M.G.J. de; Jolink, H.; Halkes, C.J.M.; Heiden, P.L.J. van der; Kremer, D.; Falkenburg, J.H.F.; Vosse, E. van de & Dissel, J.T. van (2011), Influence of Polymorphisms in Innate Immunity Genes on Susceptibility to Invasive Aspergillosis after Stem Cell Transplantation, PLoS ONE 6(4).
- Wetering, D. van de; Wengen, A. van; Savage, N.D.L.; Vosse, E. van de & Dissel, J.T. van (2011), IFN-alpha cannot substitute lack of IFN-gamma responsiveness in cells of an IFN-gamma R1 deficient patient, Clinical Immunology 138(3): 282-290.
- Boer, M.G.J. de; Gelinck, L.B.S.; Zelst, B.D. van; Sande, W.W.J. van de; Willems, L.N.A.; Dissel, J.T. van; Jonge, R. de & Kroon, F.P. (2011), beta-D-Glucan and S-adenosylmethionine serum levels for the diagnosis of Pneumocystis pneumonia in HIV-negative Patients: A prospective study, Journal of Infection 62(1): 93-100.
- Paus, R.A. de; Kilic, S.S.; Dissel, J.T. van & Vosse, E. van de (2011), Effect of amino acid substitutions in the human IFN-gamma R2 on IFN-gamma responsiveness, Genes and Immunity 12(2): 136-144.
- Benard, A.; Sighem, A. van; Taieb, A.; Valadas, E.; Ruelle, J.; Soriano, V.; Calmy, A.; Balotta, C.; Damond, F.; Brun-Vezinet, F.; Chene, G.; Matheron, S. & ACHIEV2E Collaboration Study Grp (2011), Immunovirological Response to Triple Nucleotide Reverse-Transcriptase Inhibitors and Ritonavir-Boosted Protease Inhibitors in Treatment-Naive HIV-2-Infected Patients: The ACHI(E)V(2E) Collaboration Study Group, Clinical Infectious Diseases 52(10): 1257-1266.
- Cain, L.E.; Logan, R.; Robins, J.M.; Sterne, J.A.C.; Sabin, C.; Bansi, L.; Justice, A.; Goulet, J.; Sighem, A. van; Wolf, F. de; Bucher, H.C.; Wyl, V. von; Esteve, A.; Casabona, J.; Amo, J. del; Moreno, S.; Seng, R.; Meyer, L.; Perez-Hoyos, S.; Muga, R.; Lodi, S.; Lanoy, E.; Costagliola, D.; Hernan, M.A. & HIV-CAUSAL Collaboration (2011), When to Initiate Combined Antiretroviral Therapy to Reduce Mortality and AIDS-Defining Illness in HIV-Infected Persons in Developed Countries An Observational Study, Annals of Internal Medicine 154(8): 509W173.
- Gras, L.; Sighem, A. van; Bezemer, D.; Smit, C.; Wit, F.; Wolf, F. de & ATHENA Natl Observational Cohort S (2011), Lower mortality and earlier start of combination antiretroviral therapy in patients tested repeatedly for HIV than in those with a positive first test, AIDS 25(6): 813-818.
- Sauerborn, M.; Vosse, E. van de; Delawi, D.; Dissel, J.T. van; Brinks, V. & Schellekens, H. (2011), Natural Antibodies Against Bone Morphogenic Proteins and Interferons in Healthy Donors and in Patients with Infections Linked to Type-1 Cytokine Responses, Journal of Interferon and Cytokine Research 31(9): 661-669.
- Dissel, J.T. van; Soonawala, D.; Joosten, S.A.; Prins, C.; Arend, S.M.; Bang, P.; Tingskov, P.N.; Lingnau, K.; Nouta, J.; Hoff, S.T.; Rosenkrands, I.; Kromann, I.; Ottenhoff, T.H.M.; Doherty, T.M. & Andersen, P. (2011), Ag85B-ESAT-6 adjuvanted with IC31 (R) promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection, Vaccine 29(11): 2100-2109.
- Boer, M.G.J. de; Kroon, F.P.; Cessie, S. le; Fijter, J.W. de & Dissel, J.T. van (2011), Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis.
- Jolink, H.; Dissel, J.T. van; Falkenburg, J.H.F. & Heemskerk, M.H.M. (2011), Occurrence of T Cells Specific for the Aspergillus Proteins Crf1 and Catalase1 in Patients Recovering From Invasive Aspergillosis, Blood 118(21): 1296-1296.
- Bauer, M.P.; Notermans, D.W.; Benthem, B.H.B. van; Brazier, J.S.; Wilcox, M.H.; Rupnik, M.; Monnet, D.L.; Dissel, J.T. van; Kuijper, E.J. & ECDIS Study Grp (2011), Clostridium difficile infection in Europe: a hospital-based survey.
- Roukens, A.H.; Soonawala, D.; Joosten, S.A.; Visser, A.W. de; Jiang, X.H.; Dirksen, K.; Gruijter, M. de; Dissel, J.T. van; Bredenbeek, P.J. & Visser, L.G. (2011), Elderly Subjects Have a Delayed Antibody Response and Prolonged Viraemia following Yellow Fever Vaccination: A Prospective Controlled Cohort Study, PLoS ONE 6(12): -.
- Boer, M.G.J. de; Kroon, F.P.; Cessie, S. le; Fijter, J.W. de & Dissel, J.T. van (2011), Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis., Transplant Infectious Disease.
- Chai, L.Y.A.; Boer, M.G.J. de; Velden, W.J.F.M. van der; Plantinga, T.S.; Spriel, A.B. van; Jacobs, C.; Halkes, C.J.M.; Vonk, A.G.; Blijlevens, N.M.; Dissel, J.T. van; Donnelly, P.J.; Kullberg, B.J.; Maertens, J. & Netea, M.G. (2011), The Y238X Stop Codon Polymorphism in the Human β-Glucan Receptor Dectin-1 and Susceptibility to Invasive Aspergillosis, The Journal of Infectious Diseases 203(5): 736-743.
- Jolink, H.; Oorschot, E. van; Kuijper, E.J.; Drijfhout, J.W.; Dissel, J.T.; Falkenburg, J.H.F. & Heemskerk, M.H.M. (2010), Identification of Multiple HLA Class II Epitopes of Aspergillus Fumigatus by Generation of CD4+T Cell Clones Recognizing the A. Fumigatus proteins Crf1 and Catalase1., Blood 116(21): 963-963.
- Nieuwkoop, C. van; Voorham-van der Zalm, P.J.; Laar, A.M. van; Elzevier, H.W.; Blom, J.W.; Dekkers, O.M.; Pelger, R.C.M.; Aartrijk-van Dalen, A.M. van; Tol, M.C. van & Dissel, J.T. van (2010), Pelvic floor dysfunction is not a risk factor for febrile urinary tract infection in adults, BJU International 105(12): 1689-1695.
- Starre, W.E. van der; Nieuwkoop, C. van; Paltansing, S.; van't Wout, J.W.; Groeneveld, G.H.; Becker, M.J.; Koster, T.; Wattel-Louis, G.H.; Delfos, N.M.; Ablij, H.C.; Leyten, E.M.S.; Blom, J.W. & Dissel, J.T. van (2010), Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection., Journal of Antimicrobial Chemotherapy.
- Vosse, E. van de; Ottenhoff, T.H.M.; Paus, R.A. de; Verhard, E.M.; Boer, T. de; Dissel, J.T. van & Kuijpers, T.W. (2010), Mycobacterium bovis BCG-itis and cervical lymphadenitis due to Salmonella enteritidis in a patient with complete interleukin-12/-23 receptor beta1 deficiency.
- Sighem, A. van; Gras, L.; Reiss, P.; Brinkman, K.; Wolf, F. de & ATHENA Natl Observational Cohort S (2010), Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals, AIDS 24(10): 1527-1535.
- Friis-Moller, N.; Thiebaut, R.; Reiss, P.; Weber, R.; Monforte, A.D.; Wit, S. de; El-Sadr, W.; Fontas, E.; Worm, S.; Kirk, O.; Phillips, A.; Sabin, C.A.; Lundgren, J.D.; Law, M.G. & DAD Study Grp (2010), Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study, European Journal of Cardiovascular Prevention and Rehabilitation 17(5): 491-501.
- Nieuwkoop, C. van; Bonten, T.N.; van't Wout, J.W.; Kuijper, E.J.; Groeneveld, G.H.; Becker, M.J.; Koster, T.; Wattel-Louis, G.H.; Delfos, N.M.; Ablij, H.C.; Leyten, E.M.S. & Dissel, J.T. van (2010), Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study, Critical Care 14(6).
- Kuijper, E.J. & Dissel, J.T. van (2010), Opmars van resistente gramnegatieve bacteriën , Nederlands Tijdschrift voor Geneeskunde 154(45): A2868.
- Ottenhoff, T.H.; Doherty, T.M.; Dissel, J.T. van; Bang, P.; Lingnau, K.; Kromann, I. & Andersen, P. (2010), First in humans: A new molecularly defined vaccine shows excellent safety and strong induction of long-lived Mycobacterium tuberculosis-specific Th1-cell like responses, Human Vaccines 6(12): 1007-1015.
- Nieuwkoop, C. van; van't Wout, J.W.; Spelt, I.C.; Becker, M.; Kuijper, E.J.; Blom, J.W.; Assendelft, W.J.J. & Dissel, J.T. van (2010), Prospective cohort study of acute pyelonephritis in adults: Safety of triage towards home based oral antimicrobial treatment, Journal of Infection 60(2): 114-121.
- Bezemer, D.; Sighem, A. van; Lukashov, V.V.; Hoek, L. van der; Back, N.; Schuurman, R.; Boucher, C.A.B.; Claas, E.C.J.; Boerlijst, M.C.; Coutinho, R.A.; Wolf, F. de & ATHENA Observational Cohort (2010), Transmission networks of HIV-1 among men having sex with men in the Netherlands, AIDS 24(2): 271-282.
- Bergkamp, C.H.M.; Nieuwkoop, C. van; Dissel, J.T. van & Elzevier, H.W. (2010), Re: Minardi et al.: The role of uroflowmetry biofeedback and biofeedback training of the pelvic floor muscles in the treatment of recurrent urinary tract infections in women with dysfunctional voiding: A randomized controlled prospective study (Urology 2010;75:1299-1306), Urology 76(5): 1270-1271.
- Nieuwkoop, C. van; Hoppe, B.P.C.; Bonten, T.N.; van't Wout, J.W.; Aarts, N.J.M.; Mertens, B.J.; Leyten, E.M.S.; Koster, T.; Wattel-Louis, G.H.; Delfos, N.M.; Ablij, H.C.; Elzevier, H.W. & Dissel, J.T. van (2010), Predicting the Need for Radiologic Imaging in Adults with Febrile Urinary Tract Infection, Clinical Infectious Diseases 51(11): 1266-1272.
- Nieuwkoop, C. van; Exter, P.L. den; Elzevier, H.W.; Hartigh, J. den & Dissel, J.T. van (2010), Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation, International Journal of Antimicrobial Agents 36(6): 485-490.
- Does, A.M. van der; Beekhuizen, H.; Ravensbergen, B.; Vos, T.; Ottenhoff, T.H.M.; Dissel, J.T. van; Drijfhout, J.W.; Hiemstra, P.S. & Nibbering, P.H. (2010), LL-37 Directs Macrophage Differentiation toward Macrophages with a Proinflammatory Signature, Journal of Immunology 185(3): 1442-1449.
- Ottenhoff, T.H.; Doherty, T.M.; Dissel, J.T. van; Bang, P.; Lingnau, K.; Kromann, I. & Andersen, P. (2010), First in humans: a new molecularly defined vaccine shows excellent safety and strong induction of long-lived Mycobacterium tuberculosis-specific Th1-cell like responses., Human Vaccines 6(12): 1007-15.
- Haverkamp, M.H.; Lindeboom, J.A.; Visser, A.W. de; Kremer, D.; Kuijpers, T.W.; Vosse, E. van de & Dissel, J.T. van (2010), Nontuberculous mycobacterial cervicofacial lymphadenitis in children from the multicenter, randomized, controlled trial in The Netherlands: Relevance of polymorphisms in candidate host immunity genes, International Journal of Pediatric Otorhinolaryngology 74(7): 752-754.
- Roukens, A.H.; Vossen, A.C.; Boland, G.J.; Verduyn, W.; Dissel, J.T. van & Visser, L.G. (2010), Intradermal hepatitis B vaccination in non-responders after topical application of imiquimod (Aldara (R)), Vaccine 28(26): 4288-4293.
- Steingrover, R.; Garcia, E.F.; Valkengoed, I.G.M. van; Bekker, V.; Bezemer, D.; Kroon, F.P.; Dekker, L.; Prins, M.; Wolf, F. de; Lange, J.M.A. & Prins, J.M. (2010), Transient Lowering of the Viral Set Point After Temporary Antiretroviral Therapy of Primary HIV Type 1 Infection, AIDS Research and Human Retroviruses 26(4): 379-387.
- Dissel, J.T. van; Arend, S.M.; Prins, C.; Bang, P.; Tingskov, P.N.; Lingnau, K.; Nouta, J.; Klein, M.R.; Rosenkrands, I.; Ottenhoff, T.H.M.; Kromann, I.; Doherty, T.M. & Andersen, P. (2010), Ag85B-ESAT-6 adjuvanted with IC31 (R) promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naive human volunteers, Vaccine 28(20): 3571-3581.
- Plas, M.J.A. van der; Dambrot, C.; Dogterom-Ballering, H.C.M.; Kruithof, S.; Dissel, J.T. van & Nibbering, P.H. (2010), Combinations of maggot excretions/secretions and antibiotics are effective against Staphylococcus aureus biofilms and the bacteria derived therefrom, Journal of Antimicrobial Chemotherapy 65(5): 917-923.
- Does, A.M. van der; Bogaards, S.J.P.; Ravensbergen, B.; Beekhuizen, H.; Dissel, J.T. van & Nibbering, P.H. (2010), Antimicrobial Peptide hLF1-11 Directs Granulocyte-Macrophage Colony-Stimulating Factor-Driven Monocyte Differentiation toward Macrophages with Enhanced Recognition and Clearance of Pathogens, Antimicrobial Agents and Chemotherapy 54(2): 811-816.
- Vosse, E. van de; Ottenhoff, T.H.M.; Paus, R.A. de; Verhard, E.M.; Boer, T. de; Dissel, J.T. van & Kuijpers, T.W. (2010), Mycobacterium bovis BCG-itis and Cervical Lymphadenitis due to Salmonella enteritidis in a Patient with Complete Interleukin-12/-23 Receptor beta 1 Deficiency, Infection 38(2): 128-130.
- Vosse, E. van de; Visser, A.W. de; Al-Attar, S.; Vossen, R.; Ali, S. & Dissel, J.T. van (2010), Distribution of CFTR Variations in an Indonesian Enteric Fever Cohort, Clinical Infectious Diseases 50(9): 1231-1237.
- Nieuwkoop, C. van; Bonten, T.N.; van't Wout, J.W.; Becker, M.J.; Groeneveld, G.H.; Jansen, C.L.; Vorm, E.R. van der; IJzerman, E.P.; Rothbarth, P.H.; TerMeer-Veringa, E.M.; Kuijper, E.J. & Dissel, J.T. van (2010), Risk Factors for Bacteremia with Uropathogen Not Cultured from Urine in Adults with Febrile Urinary Tract Infection, Clinical Infectious Diseases 50(11): E69E72.
- Stijnis, C.; Nieuwkoop, C. van & Dissel, J.T. van (2010), Procalcitonin-Based Guidelines and Lower Respiratory Tract Infections, Journal of the American Medical Association 303(5): 418-419.
- Wetering, D. van de; Paus, R.A. de; Dissel, J.T. van & Vosse, E. van de (2010), Functional analysis of naturally occurring amino acid substitutions in human IFN-gamma R1, Molecular Immunology 47(5): 1023-1030.
- Paassen, J. van; Bauer, M.P.; Dissel, J.T. van; Visser, L.G.; Vossen, A.C.T.M. & Arbous, M.S. (2010), Viral haemorrhagic fever in returned travellers; a review on clinical symptoms, management, and outbreak prevention, NETHERLANDS JOURNAL OF CRITICAL CARE 14(2): 98-106.
- van de Vosse E, van Dissel JT & Ottenhoff THM (2009), Genetic deficiencies of innate immune signalling in human infectious disease, Lancet Infectious Diseases 9(11): 688-698.
- Kesselring AM, Wit FW, Sabin CA, Lundgren JD, Gill MJ, Gatell JM, Rauch A, Montaner JS, de Wolf F, Reiss P & Mocroft A (2009), Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy, AIDS 23(13): 1689-1699.
- Verhagen D, Beekhuizen H, Ravensbergen B, Rosendaal F, Speelman P, van Dissel J & van der Meer J (2009), GENETIC PREDISPOSITION TO INFECTIVE ENDOCARDITIS, International Journal of Antimicrobial Agents 33: S15S16.
- Bauer MP & van Dissel JT (2009), Alternative strategies for Clostridium difficile infection, International Journal of Antimicrobial Agents 33: S51S56.
- van de Vosse E, van Wengen A, van Geelen JA, de Boer M, Roos D & van Dissel JT (2009), A novel mutation in NCF1 in an adult CGD patient with a liver abscess as first presentation, Journal of Human Genetics 54(6): 313-316.
- van de Vosse E, Verhard EM, de Paus RA, Platenburg GJ, van Deutekom JCT, Aartsma-Rus A & van Dissel JT (2009), Antisense-mediated exon skipping to correct IL-12R(beta) 1 deficiency in T cells, Blood 113(19): 4548-4555.
- van de Vosse E, Verhard EM, de Paus RA, Platenburg GJ, van Deutekom JCT, Aartsma-Rus A & van Dissel JT (2009), Antisense-mediated exon skipping to correct IL-12R beta 1 deficiency in T cells. (vol 113, pg 4548, 2009), Blood 114(20): 4607-4607.
- Bauer MP, Veenendaal D, Verhoef L, Bloembergen P, van Dissel JT & Kuijper EJ (2009), Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands, Clinical Microbiology and Infection 15(12): 1087-1092.
- Bauer MP, van Dissel JT & Kuijper EJ (2009), Clostridium difficile: controversies and approaches to management, Current Opinion in Infectious Diseases 22(6): 517-524.
- Bauer MP, Kuijper EJ & van Dissel JT (2009), European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI), Clinical Microbiology and Infection 15(12): 1067-1079.
- van de Wetering D, de Paus RA, van Dissel JT & van de Vosse E (2009), IL-23 modulates CD56(+)/CD3(-) NK Cell and CD56(+)/CD3(+) NK-like T Cell function differentially from IL-12, International Immunology 21(2): 145-153.
- Kik SV, Franken WPJ, Arend SM, Mensen M, Cobelens FGJ, Kamphorst M, van Dissel JT, Borgdorff MW & Verver S (2009), Interferon-gamma release assays in immigrant contacts and effect of remote exposure to Mycobacterium tuberculosis, International Journal of Tuberculosis and Lung Disease 13(7): 820-828.
- van der Plas MJA, van Dissel JT & Nibbering PH (2009), Maggot Secretions Skew Monocyte-Macrophage Differentiation Away from a Pro-Inflammatory to a Pro-Angiogenic Type, PLoS ONE 4(11).
- van der Plas MJA, Baldry M, van Dissel JT, Jukema GN & Nibbering PH (2009), Maggot secretions suppress pro-inflammatory responses of human monocytes through elevation of cyclic AMP, Diabetologia 52(9): 1962-1970.
- Timmers MS, Graafland N, Bernards AT, Nelissen RGHH, van Dissel JT & Jukema GN (2009), Negative pressure wound treatment with polyvinyl alcohol foam and polyhexanide antiseptic solution instillation in posttraumatic osteomyelitis, Wound Repair and Regeneration 17(2): 278-286.
- van Dissel JT & Kuijper EJ (2009), Rapidly Growing Mycobacteria: Emerging Pathogens in Cosmetic Procedures of the Skin, Clinical Infectious Diseases 49(9): 1365-1368.
- Roukens AH, Vossen AC, van Dissel JT & Visser LG (2009), Reduced intradermal test dose of yellow fever vaccine induces protective immunity in individuals with egg allergy, Vaccine 27(18): 2408-2409.
- Timen A, Koopmans MPG, Vossen ACTM, van Doornum GJJ, Gunther S, van den Berkmortel F, Verduin KM, Dittrich S, Emmerich P, Osterhaus ADME, van Dissel JT & Coutinho RA (2009), Response to Imported Case of Marburg Hemorrhagic Fever, the Netherlands, Emerging Infectious Disease 15(8): 1171-1175.
- Gelinck LBS, Jol-van der Zijde CA, Jansen-Hoogendijk AA, Brinkman DMC, van Dissel JT, van Tol MJD & Kroon FP (2009), Restoration of the antibody response upon rabies vaccination in HIV-infected patients treated with HAART, AIDS 23(18): 2451-2458.
- van de Wetering D, de Paus RA, van Dissel JT & van de Vosse E (2009), Salmonella Induced IL-23 and IL-1 beta Allow for IL-12 Production by Monocytes and M-phi-1 through Induction of IFN-gamma in CD56(+) NK/NK-Like T Cells, PLoS ONE 4(12).
- van Nieuwkoop C, van't Wout JW, Assendelft WJJ, Elzevier HW, Leyten EMS, Koster T, Wattel-Louis GH, Delfos NM, Ablij HC, Kuijper EJ, Pander J, Blom JW, Spelt IC & van Dissel JT (2009), Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days), BMC Infectious Diseases 9.
- Franken WPJ, Thijsen S, Wolterbeek R, Bouwman JJM, el Bannoudi H, Kik SV, van Dissel JT & Arend SM (2009), Variation in T-SPOT.TB Spot Interpretation between Independent Observers from Different Laboratories, Clinical and Vaccine Immunology 16(10): 1439-1442.
- Bauer MP, van Burgel ND, Marijt WAE, van Dissel JT & von dem Borne PA (2009), Fever, Shock, and Pancytopenia in a Patient Treated with Alemtuzumab, Clinical Infectious Diseases 49(10): 1540+.
- Kuijper EJ & van Dissel JT (2008), Spectrum of Clostridium difficile infections outside health care facilities, CMAJ 179(8).
- Franken WPJ, Arend SM, Thijsen SFT, Bouwman JJM, Koster BFPJ, van Dissel JT & Bossink AWJ (2008), Interferon-gamma release assays during follow-up of tuberculin skin test-positive contacts.
- Lupetti A, van Dissel JT, Brouwer CPJM & Nibbering PH (2008), Human antimicrobial peptides' antifungal activity against Aspergillus fumigatus, European Journal of Clinical Microbiology and Infectious Diseases 27(11).
- de Paus RA, van de Wetering D, van Dissel JT & van de Vosse E (2008), IL-23 and IL-12 responses in activated human T cells retrovirally transduced with IL-23 receptor variants, Molecular Immunology 45(15).
- Sabin CA, Monforte AD, Friis-Moller N, Weber R, El-Sadr WM, Reiss P, Kirk O, Mercie P, Law MG, De Wit S, Pradier C, Phillips AN & Lundgren JD (2008), Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction, Clinical Infectious Diseases 46(7).
- van der Plas MJA, Jukema GN, Wai SW, Dogterom-Ballering HCM, Lagendijk EL, van Gulpen C, van Dissel JT, Bloemberg GV & Nibbering PH (2008), Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa, Journal of Antimicrobial Chemotherapy 61(1).
- van Nieuwkoop C, Tijsterman JD & van Dissel JT (2008), Gather ye buds - Fungus formation of the bladder after complicated cesarean section, American Journal of Obstetrics and Gynecology 199(2).
- Keijser S, Jager MJ, Dogterom-Ballering HCM, Schoonderwoerd DT, de Keizer RJW, Krose CJM, Houwing-Duistermaat JJ, van der Plas MJA, van Dissel JT & Nibbering PH (2008), Lactoferrin Glu561Asp polymorphism is associated with susceptibility to herpes simplex keratitis, Experimental Eye Research 86(1).
- Ramautar R, Mayboroda OA, Derks RJE, van Nieuwkoop C, van Dissel JT, Sornsen GW, Deelder AM & de Jong GJ (2008), Capillary electrophoresis-time of flight-mass spectrometry using noncovalently bilayer-coated capillaries for the analysis of amino acids in human urine, ELECTROPHORESIS 29(12).
- Goorhuis A, van Dissel JT & Kuijper EJ (2008), Novel risk factors for Clostridium difficile-associated disease in a setting of endemicity?, Clinical Infectious Diseases 47(3).
- Schippers EF, Berbee JFP, van Disseldorp IM, Versteegh MIM, Havekes LM, Rensen PCN & van Dissel JT (2008), Preoperative apolipoprotein CI levels correlate positively with the proinflammatory response in patients experiencing endotoxemia following elective cardiac surgery, Intensive Care Medicine 34(8).
- Roukens, A.H.; Vossen, A.C.; Dissel, J.T. van & Visser, L.G. (2008), Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults, Vaccine 26(27-28).
- Baker S, Holt K, van de Vosse E, Roumagnac P, Whitehead S, King E, Ewels P, Keniry A, Weill FX, Lightfoot D, van Dissel JT, Sanderson KE, Farrar J, Achtman M, Deloukas P & Dougan G (2008), High-throughput genotyping of Salmonella enterica serovar typhi allowing geographical assignment of Haplotypes and pathotypes within an urban district of Jakarta, Indonesia, Journal of Clinical Microbiology 46(5).
- de Boer T, van Dissel JT, Kuijpers TWJ, Rimmelzwaan GF, Kroon FP & Ottenhoff THM (2008), Influenza virus vaccination induces interleukin-12/23 receptor beta 1 (IL-12/23R beta 1)-independent production of gamma interferon (IFN-gamma) and humoral immunity in patients with genetic deficiencies in IL-12/23R beta 1 or IFN-gamma receptor I, Clinical and Vaccine Immunology 15(8).
- Arend SM, Franken WPJ, Aggerbeck H, Prins C, van Dissel JT, Thierry-Carstensen B, Tingskov PN, Weldingh K & Andersen P (2008), Double-blind randomized Phase I study comparing rdESAT-6 to tuberculin as skin test reagent in the diagnosis of tuberculosis infection, Tuberculosis 88(3).
- Bauer MP, Goorhuis A, Koster T, Numan-Ruberg SC, Hagen EC, Debast SB, Kuijper EJ & van Dissel JT (2008), Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage, Netherlands Journal of Medicine 66(5).
- Roukens, A.H.E.; Boland, G.J.; Vossen, A.C.T.M.; Dissel, J.T. van & Visser, L.G. (2008), Intradermal Hepatitis B Vaccination in Non-responders after Topical Application of Imiquimod (Aldara™) on the Vaccinated Skin, Vaccine.
- van der Eijk EA, van de Vosse E, Vandenbroucke JP & van Dissel JT (2007), Heredity versus environment in tuberculosis in twins - The 1950s United Kingdom Prophit survey - Simonds and Comstock revisited, American Journal of Respiratory and Critical Care Medicine 176(12).
- Leyten EMS, Prins C, Bossink AWJ, Thijsen S, Ottenhoff THM, van Dissel JT & Arend SM (2007), Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-gamma assay, European Respiratory Journal 29(6).
- Ali S, Vollaard AM, Kremer D, de Visser AW, Martina CAE, Widjaja S, Surjadi C, Slagboom E, van de Vosse E & Van Dissel JT (2007), Polymorphisms in proinflammatory genes and susceptibility to typhoid fever and paratyphoid fever, Journal of Interferon and Cytokine Research 27(4).
- van Diepen A, Martina CAE, Flierman R, Janssen R & van Dissel JT (2007), Treatment with anti-TNF alpha does not induce reactivation of latent Salmonella enterica serovar Typhimurium infection in C3H/HeN mice, Scandinavian Journal of Immunology 65(5).
- Kuijper EJ, van Dissel JT & Wilcox MH (2007), Clostridium difficile: changing epidemiology and new treatment options, Current Opinion in Infectious Diseases 20(4).
- van Nieuwkoop C & van Dissel JT (2007), Posaconazole prophylaxis in hematologic cancer, New England Journal of Medicine 356(21).
- Leyten EMS, Arend SM, Prins C, Cobelens FGJ, Ottenhoff THM & van Dissel JT (2007), Discrenancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation, Clinical and Vaccine Immunology 14(7).
- Sahiratmadja E, Baak-Pablo R, Visser AW, Alisjahbana B, Adnan I, van Crevel R, Marzuki S, van Dissel JT, Ottenhoff THM & van de Vosse E (2007), Association of polymorphisms in IL-12/IFN-gamma pathway genes with susceptibility to pulmonary tuberculosis in Indonesia, Tuberculosis 87(4).
- Numan SC, Veldkamp P, Kuijper EJ, van den Berg RJ & van Dissel JT (2007), Clostridium difficile-associated diarrhoea: bovine anti-Clostridium difficile whey protein to help aid the prevention of relapses, Gut 56(6).
- Roukens, A.H.E.; Dissel, J.T. van; Fijter, J.W. de & Visser, L.G. (2007), Health preparations and travel-related morbidity of kidney transplant recipients traveling to developing countries, Clinical Transplantation 21(4).
- van der Plas MJA, van der Does AM, Baldry M, Dogterom-Ballering HCM, van Gulpen C, van Dissel JT, Nibbering PH & Jukema GN (2007), Maggot excretions/secretions inhibit multiple neutrophil pro-inflammatory responses, Microbes and Infection 9(4).
- Noordzij JG, Hartwig NG, Verreck FAW, de Bruin-Versteeg S, de Boer T, van Dissel JT, de Groot R, Ottenhoff THM & van Dongen JJM (2007), Two patients with complete defects in interferon gamma receptor-dependent signaling, Journal of Clinical Immunology 27(5).
- Franken WPJ, Timmermans JF, Prins C, Slootman EJHJ, Dreverman J, Bruins H, van Dissel JT & Arend SM (2007), Comparison of Mantoux and QuantiFERON TB gold tests for diagnosis of latent tuberculosis infection in army personnel, Clinical and Vaccine Immunology 14(4).
- Franken WPJ, Koster BFPJ, Bossink AWJ, Thijsen SFT, Bouwman JJM, van Dissel JT & Arend SM (2007), Follow-up study of tuberculosis-exposed supermarket customers with negative tuberculin skin test results in association with positive gamma interferon release assay results, Clinical and Vaccine Immunology 14(9).
- van Bruggen R, Zweers D, van Diepen A, van Dissel JT, Roos D, Verhoeven AJ & Kuijpers TW (2007), Complement receptor 3 and toll-like receptor 4 act sequentially in uptake and intracellular killing of unopsonized Salmonella enterica serovar typhimurium by human neutrophils, Infection and Immunity 75(6).
- Arend SM, Leyten EMS, Franken WPJ, Huisman EM & van Dissel JT (2007), A patient with de novo tuberculosis during anti-tumor necrosis factor-alpha therapy illustrating diagnostic pitfalls and paradoxical response to treatment, Clinical Infectious Diseases 45(11).
- Young KWH, Munro IC, Taylor SL, Veldkamp P & van Dissel JT (2007), The safety of whey protein concentrate derived from the milk of cows immunized against Clostridium difficile, Regulatory Toxicology and Pharmacology 47(3).
- Lupetti A, Brouwer CPJM, Bogaards SJP, Welling MM, de Heer E, Campa M, van Dissel JT, Friesen RHE & Nibbering PH (2007), Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicans infection, Journal of Infectious Diseases 196(9).
- Walenkamp MJE, Vidarsdottir S, Pereira AM, Karperien M, van Doorn J, van Duyvenvoorde HA, Breuning MH, Roelfsema F, Kruithof MF, van Dissel J, Janssen R, Wit JM & Romijn JA (2007), Growth hormone secretion and immunological function of a male patient with a homozygous STATSb mutation, European Journal of Endocrinology 156(2).
- Jukema G.N., Steenvoorde P., Wong C.Y., Bernards A.T. & Dissel J.T. van (2006), Maden: Ein neues Konzept in der Behandlung von Infektionen in der Traumatologie ; "Back to the Future!", Zentralblatt für Chirurgie 131: S75-S78.
- Boks T, van Dissel JT, Teterissa N, Ros F, Mahmut MH, Utama ED, Rol M, van Asdonk P, Airiani S & van Meurs JC (2006), An outbreak of endophthalmitis after extracapsular cataract surgery probably caused by endotoxin contaminated distilled water used to dissolve acetylcholine, British Journal of Ophthalmology 90(9).
- Berbee JFP, van der Hoogt CC, Kleemann R, Schippers EF, Kitchens RL, van Dissel JT, Bakker-Woudenberg IAJM, Havekes LM & Rensen PCN (2006), Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in Gram-negative sepsis, FASEB Journal 20(12).
- Vidarsdottir S, Walenkamp MJE, Pereira AM, Karperien M, van Doorn J, van Duyvenvoorde HA, White S, Breuning MH, Roelfsema F, Kruithof MF, van Dissel J, Janssen R, Wit JM & Romijn JA (2006), Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation, Journal of Clinical Endocrinology and Metabolism 91(9).
- Haverkamp MH, van Dissel JT & Holland SM (2006), Human host genetic factors innontuberculous mycobacterial infection: lessons from single gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferon-gamma-dependent signaling, Microbes and Infection 8(4).
- Ali S, Vollaard AM, Widjaja S, Surjadi C, van de Vosse E & van Dissel JT (2006), PARK2/PACRG polymorphisms and susceptibility to typhoid and paratyphoid fever, Clinical and Experimental Immunology 144(3).
- Jukema GN, Steenvoorde P, Wong CY, Bernards AT & van Dissel JT (2006), Maggot therapy for treatment of severe infections in trauma surgery: "Back to the future!", Zentralblatt f�r Chirurgie 131.
- Leyten EMS, Mulder B, Prins C, Weldingh K, Andersen P, Ottenhoff THM, van Dissel JT & Arend SM (2006), Use of enzyme-linked immunospot assay with Mycobacterium tuberculosis-specific peptides for diagnosis of recent infection with m. tuberculosis after accidental laboratory exposure, Journal of Clinical Microbiology 44(3).
- Vollaard AM, Verspaget HW, Ali S, Visser LG, Veenendaal RA, Van Asten HAGH, Widjaja S, Surjadi C & Van Dissel JT (2006), Helicobacter pylori infection and typhoid fever in Jakarta, Indonesia, Epidemiology and Infection 134(1).
- Litjens NHR, Rademaker M, Ravensbergen B, Thio HB, van Dissel JT & Nibbering PH (2006), Effects of monomethylfumarate on dendritic cell differentiation, British Journal of Dermatology 154(2).
- Vollaard, A.M.; Verspaget, H.W.; Ali, S.; Visser, L.G.; Veenendaal, R.A.; Asten, H.A.G.H. van; Widjaja, S.; Surjadi, C. & Dissel, J.T. van (2006), Helicobacter pylori infection and typhoid fever in Jakarta, Indonesia, Epidemiology & Infection 134(1): 163-170.
- van Dissel JT, de Groot N, Hensgens CMH, Numan S, Kuijper EJ, Veldkamp P & van't Wout J (2005), Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile associated diarrhoea: preclinical and preliminary clinical data, Journal of Medical Microbiology 54(2).
- Arend SM, de Haas P, Leyten E, Rosenkrands I, Rigouts L, Andersen P, Mijs W, van Dissel JT & van Soolingen D (2005), ESAT-6 and CFP-10 in clinical versus environmental isolates of Mycobacterium kansasii, Journal of Infectious Diseases 191(8).
- Schippers EF, van't Veer C, van Voorden S, Martina CAE, Huizinga TWJ, le Cessie S & van Dissel JT (2005), IL-10 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin, Cytokine 29(5).
- Van Dissel JT, Numan SC & Van't Wout JW (2005), Chills in 'early sepsis': good for you?, Journal of Internal Medicine 257(5).
- van Diepen A, van de Gevel JS, Koudijs MM, Ossendorp F, Beekhuizen H, Janssen R & van Dissel JT (2005), Gamma irradiation or CD4(+)-T-cell depletion causes reactivation of latent Salmonella enterica serovar Typhimurium infection in C3H/HeN mice, Infection and Immunity 73(5).
- Gan IM, Ugahary LC, van Dissel JT, Feron E, Peperkamp E, Veckeneer M, Mulder PGH, Platenkamp GJ & van Meurs JC (2005), Intravitreal dexamethasone as adjuvant in the treatment of postoperative endophthalmitis: a prospective randomized trial, Graefe's Archive for Clinical and Experimental Ophthalmology 243(12).
- van de Vosse E, Ali S, de Visser AW, Surjadi C, Widjaja S, Vollaard AM & van Dissel JT (2005), Susceptibility to typhoid fever is associated with a polymorphism in the cystic fibrosis transmembrane conductance regulator (CFTR), Human Genetics 118(1).
- Vollaard, A.M.; Ali, S.; Widjaja, S.; Asten, H.A.G.H. van; Visser, L.G.; Surjadi, C. & Dissel, J.T. van (2005), Identification of typhoid fever and paratyphoid fever cases at presentation in outpatient clinics in Jakarta, Indonesia, Transactions of The Royal Society of Tropical Medicine and Hygiene 99(6).
- Mattie H, Stuertz K, Nau R & van Dissel JT (2005), Pharmacodynamics of antibiotics with respect to bacterial killing of and release of lipoteichoic acid by Streptococcus pneumoniae, Journal of Antimicrobial Chemotherapy 56(1).
- Dorman SE, Picard C, Lammas D, Heyne K, van Dissel JT, Baretto R, Rosenzweig SD, Newport M, Levin M, Roesler J, Kumararatne D, Casanova JL & Holland SM (2004), Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies, Lancet 364(9451).
- van der Straaten T, Zulianello L, van Diepen A, Granger DL, Janssen R & van Dissel JT (2004), Salmonella enterica serovar typhimurium RamA, intracellular oxidative stress response, and bacterial virulence, Infection and Immunity 72(2).
- Litjens NHR, Burggraaf J, van Strijen E, van Gulpen C, Mattie H, Schoemaker RC, van Dissel JT, Thio HB & Nibbering PH (2004), Pharmacokinetics of oral fumarates in healthy subjects, British Journal of Clinical Pharmacology 58(4).
- Litjens NHR, van der Plas MJA, Ravensbergen B, Numan-Ruberg SC, van Assen Y, Thio HB, van Dissel JT, van de Vosse E & Nibbering PH (2004), Psoriasis is not associated with IL-12p70/IL-12p40 production and IL12B promoter polymorphism, Journal of Investigative Dermatology 122(4).
- Lupetti A, Brouwer CPJM, Dogterom-Ballering HEC, Senesi S, Campa M, van Dissel JT & Nibbering PH (2004), Release of calcium from intracellular stores and subsequent uptake by mitochondria are essential for the candidacidal activity of an N-terminal peptide of human lactoferrin, Journal of Antimicrobial Chemotherapy 54(3).
- Litjens NHR, Rademaker M, Ravensbergen B, Rea D, van der Plas MJA, Thio B, Walding A, van Dissel JT & Nibbering PH (2004), Monomethylfumarate affects polarization of monocyte-derived dendritic cells resulting in downregulated Th1 lymphocyte responses, European Journal of Immunology 34(2).
- Levelink B, de Vries E, van Dissel JT & van Dongen JJM (2004), Pulmonary Mycobacterium avium introcellulare infection in an immunocompetent child, Pediatric Infectious Disease Journal 23(9).
- Rensen PCN, Berbeel JFP, Schippers EF, van Dissel JT, Bakker-Woudenberg AJM, van Leeuwen HJ, de Haas CJC, van Kessel KPM, van Berkel TJC, Kuiper J, Kooistra T & Havekes LM (2004), Apolipoproteins modulate inflammatory responses in rodents and humans: Implications for sepsis, Shock 21.
- Berbee JFP, Schippers EF, van Dissel JT, Havekes LM & Rensen PCN (2004), ApoCI improves the inflammatory response to LPS in mice and humans: A new therapeutic approach to treat sepsis, Shock 21.
- Janssen R, van Wengen A, Hoeve MA, ten Dam M, van der Burg M, van Dongen J, van de Vosse E, van Tol M, Bredius R, Ottenhoff TH, Weemaes C, van Dissel JT & Lankester A (2004), The same I kappa KB alpha mutation in two related individuals leads to completely different clinical syndromes, Journal of Experimental Medicine 200(5).
- Arend SM, de Palou EC, de Haas P, Janssen R, Hoeve MA, Verhard EM, Ottenhoff THM, van Soolingen D & van Dissel JT (2004), Pneumonia caused by Mycobacterium kansasii in a series of patients without recognised immune defect, Clinical Microbiology and Infection 10(8).
- Schippers EF, van t' Veer C, , Martina CAE, Le Cessie S & Van Dissel JT (2004), TNF-alpha promoter, Nod2 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin, Cytokine 26(1).
- Vollaard, A.M.; Ali, S.; Asten, H.A.G.H. van; Widjaja, S.; Visser, L.G.; Surjadi, C. & Dissel, J.T. van (2004), Risk factors for typhoid and paratyphoid fever in Jakarta, Indonesia, Journal of the American Medical Association 291(21).
- van der Straaten T, Janssen R, Mevius DJ & van Dissel JT (2004), Salmonella gene rma (ramA) and multiple-drug-resistant Salmonella enterica serovar Typhimurium, Antimicrobial Agents and Chemotherapy 48(6).
- Vollaard, A.M.; Ali, S.; Asten, H.A.G.H. van; Ismid, I.S.; Widjaja, S.; Visser, L.G.; Surjadi, C. & Dissel, J.T. van (2004), Risk factors for transmission of foodborne illness in restaurants and street vendors in Jakarta, Indonesia, Epidemiology & Infection 132(5).
- Arend SM, Kuijper EJ, Allaart CF, Muller WH & van Dissel JT (2004), Cavitating pneumonia after treatment with infliximab and prednisone, European Journal of Clinical Microbiology and Infectious Diseases 23(8).
- Haverkamp MH, Arend SM, Lindeboom JA, Hartwig NG & van Dissel JT (2004), Nontuberculous mycobacterial infection in children: A 2-year prospective surveillance study in the Netherlands, Clinical Infectious Diseases 39(4).
- Janssen R, Verhard E, Lankester A, ten Cate R & van Dissel JT (2004), Enhanced interleukin-1 beta and interleukin-18 release in a patient with chronic infantile neurologic, cutaneous, articular syndrome, Arthritis and Rheumatism 50(10).
- Bosscha MI, van Dissel JT, Kuijper EJ, Swart W & Jager MJ (2004), The efficacy and safety of topical polymyxin B, neomycin and gramicidin for treatment of presumed bacterial corneal ulceration, British Journal of Ophthalmology 88(1).
- de Boer MGJ, Kroon FP, Kauffmann RH, Vriesendorp R, Zwinderman K & van Dissel JT (2003), Immune restoration disease in HIV-infected individuals receiving highly active antiretroviral therapy: clinical and immunological characteristics, Netherlands Journal of Medicine 61(12).
- Duits LA, Tjabringa GS, Aarts NJM, van't Wout JW, Hiemstra PS, Nibbering PH & van Dissel JT (2003), Plasma secretory leukocyte protease inhibitor in febrile patients - An indicator of the presence and extent of pulmonary infection, Clinical Microbiology and Infection 9(7).
- Ottenhoff THM, De Boer T, van Dissel JT & Verreck FAW (2003), Human deficiencies in type-1 cytokine receptors reveal the essential role of type-1 cytokines in immunity to intracellular bacteria, Advances in Experimental Medicine and Biology 531.
- Schippers EF & van Dissel JT (2003), Selective gut decontamination, Critical Care Medicine 31(11).
- Janssen R, van der Straaten T, van Diepen A & van Dissel JT (2003), Responses to reactive oxygen intermediates and virulence of Salmonella typhimurium, Microbes and Infection 5(6).
- Lupetti A, Paulusma-Annema A, Welling MM, Dogterom-Ballering H, Brouwer CPJM, Senesi S, van Dissel JT & Nibbering PH (2003), Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species, Antimicrobial Agents and Chemotherapy 47(1).
- Lichtenauer-Kaligis EGR, de Boer T, Verreck FAW, van Voorden S, Hoeve MA, van de Vosse E, Ersoy F, Tezcan H, van Dissel JT, Sanal O & Ottenhoff THM (2003), Severe Mycobacterium bovis BCG infections in a large series of novel IL-12 receptor beta 1 deficient patients and evidence for the existence of partial IL-12 receptor beta 1 deficiency, European Journal of Immunology 33(1).
- van Dissel JT (2003), Procalcitonin: What should be its role in the clinical management of febrile patients admitted to the hospital?, Clinical Infectious Diseases 36(6).
- Heesen M, Schippers EF, Bloemeke B, Kunz D & van Dissel JT (2003), Cytokine response to endotoxin in individuals heterozygous for the Delta 32 mutation of chemokine receptor CCR5, Cytokine 21(4).
- Litjens NHR, Nibbering PH, Barrois AJ, Zomerdijk TPL, Van den Oudenrijn AC, Noz KC, Rademaker M, Van de Meide PH, Van Dissel JT & Thio B (2003), Beneficial effects of fumarate therapy in psoriasis vulgaris patients coincide with downregulation of type 1 cytokines, British Journal of Dermatology 148(3).
- Arend SM, Breedveld FC & van Dissel JT (2003), TNF-alpha blockade and tuberculosis: better look before you leap, Netherlands Journal of Medicine 61(4).
- van de Vosse E, Lichtenauer-Kaligis EGR, van Dissel JT & Ottenhoff THM (2003), Genetic variations in the interleukin-12/interleukin-23 receptor (beta 1) chain, and implications for IL-12 and IL-23 receptor structure and function, Immunogenetics 54(12).
- Janssen R, van Wengen A, Verhard E, de Boer T, Zomerdijk T, Ottenhoff THM & van Dissel JT (2002), Divergent role for TNF-alpha in IFN-gamma-induced killing of Toxoplasma gondii and Salmonella typhimurium contributes to selective susceptibility of patients with partial IFN-gamma receptor 1 deficiency, Journal of Immunology 169(7).
- Raber-Durlacher JE, Epstein JB, Raber J, van Dissel JT, van Winkelhoff AJ, Guiot HFL & van der Velden U (2002), Periodontal infection in cancer patients treated with high-dose chemotherapy, Supportive Care in Cancer 10(6).
- Van Mierlo PJWB, De Boer SY, Van Dissel JT & Arend SM (2002), Recurrent staphylococcal bacteraemia and subhepatic abscess associated with gallstones spilled during laparoscopic cholecystectomy two years earlier, Netherlands Journal of Medicine 60(4).
- Arend SM, van Meijgaarden KE, de Boer K, de Palou EC, van Soolingen D, Ottenhoff THM & van Dissel JT (2002), Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M-kansasii, Journal of Infectious Diseases 186(12).
- Jukema GN, Menon AG, Bernards AT, Steenvoorde P, Rastegar AT & van Dissel JT (2002), Amputation-sparing treatment by nature: "Surgical" maggots revisited, Clinical Infectious Diseases 35(12).
- Ottenhoff THM, Verreck FAW, Lichtenauer-Kaligis EGR, Hoeve MA, Sanal O & van Dissel JT (2002), Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae, Nature Genetics 32(1).
- Arend SM & van Dissel JT (2002), Evidence of endogenous reactivation of tuberculosis after a long period of latency, Journal of Infectious Diseases 186(6).
- Verreck FAW, de Boer T, Hoeve M, van Dissel JT, Sanal O, Kurimoto M & Ottenhoff THM (2002), Human host defense and cytokines in mycobacterial infectious diseases: Interleukin-18 cannot compensate for genetic defects in the interleukin-12 system, Clinical Infectious Diseases 35(2).
- Lupetti A, Paulusma-Annema A, Senesi S, Campa M, van Dissel JT & Nibbering PH (2002), Internal Thiols and reactive oxygen species in candidacidal activity exerted by an N-terminal peptide of human lactoferrin, Antimicrobial Agents and Chemotherapy 46(6).
- van Diepen A, van der Straaten T, Holland SM, Janssen R & van Dissel JT (2002), A superoxide-hypersusceptible Salmonella enterica serovar Typhimurium mutant is attenuated but regains virulence in p47(phox-/-) mice, Infection and Immunity 70(5).
- Bouter H, Schippers EF, Luelmo SAC, Versteegh MIM, Ros P, Guiot HFL, Frolich M & van Dissel JT (2002), No effect of preoperative selective gut decontamination on endotoxemia and cytokine activation during cardiopulmonary bypass: A randomized, placebo-controlled study, Critical Care Medicine 30(1).
- Arend SM, Ottenhoff THM, Andersen P & van Dissel JT (2001), Uncommon presentations of tuberculosis: the potential value of a novel diagnostic assay based on the Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10, International Journal of Tuberculosis and Lung Disease 5(7).
- ten Brinke A, van Dissel JT, Sterk PJ, Zwinderman AH, Rabe KF & Bel EH (2001), Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection, Journal of Allergy and Clinical Immunology 107(3).
- Eijkhout HW, van der Meer JWM, Kallenberg CGM, Weening RS, van Dissel JT, Sanders LAM, Strengers PFW, Nienhuis H & Schellekens PTA (2001), The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia - A randomized, double-blind, multicenter crossover trial, Annals of Internal Medicine 135(3).
- Arend SM, van Soolingen D, Ottenhoff THM & van Dissel JT (2001), Repeatedly negative tuberculin skin tests followed by active tuberculosis in an immunocompetent individual, Netherlands Journal of Medicine 58(2).
- Arend SM, Dik H & van Dissel JT (2001), Good's syndrome: The association of thymoma and hypogammaglobulinemia, Clinical Infectious Diseases 32(2).
- van Dissel JT, Arend SM & Ottenhoff THM (2001), Infections with non-tuberculous mycobacteria and salmonellae in patients with genetic defects in the interleukin-12/interferon-gamma-mediated pathway of macrophage activation, Netherlands Journal of Medicine 59(3).
- Arend SM, Janssen R, Gosen JJ, Waanders H, de Boer T, Ottenhoff THM & van Dissel JT (2001), Multifocal osteomyelitis caused by nontuberculous mycobacteria in patients with a genetic defect of the interferon-gamma receptor, Netherlands Journal of Medicine 59(3).
- Gan IM, van Dissel JT, Beekhuis WH, Swart W & van Meurs JC (2001), Intravitreal vancomycin and gentamicin concentrations in patients with postoperative endophthalmitis, British Journal of Ophthalmology 85(11).
- Arend SM, Engelhard ACF, Groot G, de Boer K, Andersen P, Ottenhoff THW & van Dissel JT (2001), Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact, Clinical and Diagnostic Laboratory Immunology 8(6).
- Straaten, T. van der; Diepen, A. van; Kwappenberg, K.; Voorden, S. van; Franken, K.; Janssen, R.; Kusters, J.G.; Granger, D.L. & Dissel, J.T. van (2001), Novel Salmonella enterica serovar typhimurium protein that is indispensable for virulence and intracellular replication, Infection and Immunity 69(12).
- Arend SM, Geluk A, van Meijgaarden KE, van Dissel JT, Theisen M, Andersen P & Ottenhoff THM (2000), Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides.
- Lupetti A, Paulusma-Annema A, Welling MM, Senesi S, Van Dissel JT & Nibbering PH (2000), Candidacidal activities of human lactoferrin peptides derived from the N terminus, Antimicrobial Agents and Chemotherapy 44(12).
- van Langevelde P, Joop K, van Loon J, Frolich M, Groeneveld PHP, Westendorp RGJ & van Dissel JT (2000), Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: Identification of subjects at high risk of mortality, Clinical Infectious Diseases 31(6).
- Ottenhoff THM, de Boer T, Verhagen CE, Verreck FAW & van Dissel JT (2000), Human deficiencies in type 1 cytokine receptors reveal the essential role of type 1 cytokines in immunity to intracellular bacteria, Microbes and Infection 2(13).
- Kroon FP, van Dissel JT, Ravensbergen E, Nibbering PH & van Furth R (2000), Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults, Vaccine 19(7-8).
- Koster T, Kroes ACM & van Dissel JT (2000), Chlamydia pneumoniae IgG seropositivity in deep-vein thrombosis - Authors' reply, Lancet 356(9241).
- Verhagen CE, de Boer T, Smits HH, Verreck FAW, Wierenga EA, Kurimoto M, Lammas DA, Kumararatne DS, Sanal O, Kroon FP, van Dissel JT, Sinigaglia F & Ottenhoff THM (2000), Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta 1 (IL-12R beta 1): Evidence for an IL-12R beta 1-independent pathway of IL-12 responsiveness in human T cells.
- Kroon FP, van Dissel JT, de Jong JC, Zwinderman K & van Furth R (2000), Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study.
- Arend SM, Andersen P, van Meijgaarden KE, Skjot RLV, Subronto YW, van Dissel JT & Ottenhoff THM (2000), Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10.
- Koster T, Rosendaal F, Lieuw-A-Len DD, Kroes ACM, Emmerich JD & van Dissel JT (2000), Chlamydia pneumoniae IgG seropositivity and risk of deep-vein thrombosis.
- de Jong R, Altare F, Haagen IA, Elferink DG, de Boer T, Vriesman PJCV, Kabel PJ, Draaisma JMT, van Dissel JT, Kroon FP, Casanova JL & Ottenhoff THM (1998), Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients, Science 280(5368): 1435-1438.
- Lid spin-commissie
- Directeur centrum infectieziekte bestrijding
- Bestuurslid